Analytical Bio-Chemistry Labs (ABC Labs) opened its new 90,000- sq.-ft. pharmaceutical development facility located at the University of Missouri’s Discovery Ridge Research Park, completing the transition of the company’s DMPK, bioanalytical and CGMP Analytical operations to the new facility. The facility more than doubles the company’s previous capacity.
   
“The qualification of the new pharmaceutical facility is complete. All laboratory systems are validated, and scientific teams are quickly settling into their new home,” said John Bucksath, senior vice president and general manager of ABC’s Pharmaceutical Division. “We are wrapping up a carefully choreographed project plan—and I’m delighted to report that the transition of pharmaceutical operations went very smoothly.” In July, the FDA completed a pre-approval and General Quality Systems audit of the facility, which resulted in no 483s.
   
“This is an exciting time in ABC’s history,” says Byron E. Hill, president and chief executive officer. “This expansion provides the ideal platform for a new era of growth, productivity and exceptional client service.”

The company will continue operating its chemical services and synthesis operations at its original campus located about five miles east of Columbia. The expansion at Discovery Ridge frees up space for these areas of the business as well. The company plans to renovate existing structures in 2009 to optimize operational efficiency.